We established a partnership with the Peter Doherty Institute to test candidate antiviral compounds from international manufacturers.
We also represented Australia in a World Health Organisation meeting on COVID-19.
We had dialogues with several international consortia to establish novel diagnostic capability.
We received funding from the Coalition for Epidemic Preparedness Innovations (CEPI), a global group that aimed to speed up the development of vaccines and cut short the COVID-19 pandemic.
We commenced testing candidate vaccines from the University of Oxford (UK) and Inovio Pharmaceuticals Inc (US). This work took around three months and was conducted at the Australian Centre for Disease Preparedness in Geelong.
We established a partnership with the Peter Doherty Institute to test candidate antiviral compounds from international manufacturers.
We also represented Australia in a World Health Organisation meeting on COVID-19.
We had dialogues with several international consortia to establish novel diagnostic capability.
We received funding from the Coalition for Epidemic Preparedness Innovations (CEPI), a global group that aimed to speed up the development of vaccines and cut short the COVID-19 pandemic.
We commenced testing candidate vaccines from the University of Oxford (UK) and Inovio Pharmaceuticals Inc (US). This work took around three months and was conducted at the Australian Centre for Disease Preparedness in Geelong.